Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

Acute myeloid leukemia (AML) is considered an oncologic emergency. Delaying induction chemotherapy until molecular testing results return, may benefit some patients but harm others. We examined the effect of time from AML diagnosis to treatment (TDT) on complete remission (CR) and overall survival (...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2009
Sujets:
Clinical Trials and Observations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2614639/
https://ncbi.nlm.nih.gov/pubmed/18827183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-05-157065
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires